112 related articles for article (PubMed ID: 36744409)
1. Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021.
Yang X; Li Y; Tang Y; Li Z; Wang S; Luo X; He T; Yin A; Luo M
Emerg Microbes Infect; 2023 Dec; 12(1):e2176009. PubMed ID: 36744409
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023.
Yao X; Li Q; Chen Y; Du Z; Huang Y; Zhou Y; Zhang J; Wang W; Zhang L; Xie J; Xu C; Ge Y; Zhou Y
Front Public Health; 2024; 12():1332696. PubMed ID: 38590815
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and genotype distribution of human papillomavirus infection among women in Jingzhou, China: a population-based study of 51,720 women.
Liu S; Mei B; Ouyang Y; Li C
Virol J; 2023 Dec; 20(1):297. PubMed ID: 38102627
[TBL] [Abstract][Full Text] [Related]
4. Impact of cervical screening by human papillomavirus genotype: Population-based estimations.
Wang J; Elfström KM; Lagheden C; Eklund C; Sundström K; Sparén P; Dillner J
PLoS Med; 2023 Oct; 20(10):e1004304. PubMed ID: 37889928
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and characteristics of cervical human papillomavirus genotypes and cervical lesions among 58630 women from Guangzhou, China.
Huiyun J; Jie D; Huan W; Yuebo Y; Xiaomao L
J Infect Public Health; 2023 Oct; 16(10):1531-1536. PubMed ID: 37562080
[TBL] [Abstract][Full Text] [Related]
6. Multiple infections containing the top five prevalent HPV genotypes and their impact on cervical lesions in Changzhou, China.
Gong P; Shi B; Cong X; Yang L; Gong C; Zhou Y; Li X; Wang J
Hum Vaccin Immunother; 2023 Aug; 19(2):2245723. PubMed ID: 37584193
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of human papillomavirus prevalence and infection patterns among women aged 25-64 according to age groups and cytology results in Ordos City, China.
Wang S; Liu S; Tan S; Yin J; Li Y; Zhao F; Qiao Y
Virol J; 2024 Jan; 21(1):12. PubMed ID: 38191450
[TBL] [Abstract][Full Text] [Related]
8. High burden of human papillomavirus infection among men in Guangzhou, South China: Implications for HPV vaccination strategies.
Liu P; Yang X; Zhao H; Liang L; Chen M; Yin A
Hum Vaccin Immunother; 2024 Dec; 20(1):2337161. PubMed ID: 38566539
[TBL] [Abstract][Full Text] [Related]
9. Distribution of HPV types among women with HPV-related diseases and exploration of lineages and variants of HPV 52 and 58 among HPV-infected patients in China: A systematic literature review.
Wang M; Liang H; Yan Y; Bian R; Huang W; Zhang X; Nie J
Hum Vaccin Immunother; 2024 Dec; 20(1):2343192. PubMed ID: 38745409
[TBL] [Abstract][Full Text] [Related]
10. Cervical HPV infection in Yueyang, China: a cross-sectional study of 125,604 women from 2019 to 2022.
Hou J; Zeng M; Liu C; Xie B; Li Y; Wu L; Zhu L; Li M; Zhang Z; Zhang X; Ge Y
Front Public Health; 2023; 11():1210253. PubMed ID: 37601194
[TBL] [Abstract][Full Text] [Related]
11. HPV prevalence and distribution characteristics in postmenopausal women from Nanjing, China.
Yin X; Zhang C; Wu X; Feng J; Xie J; Li Y
BMC Womens Health; 2024 Jan; 24(1):68. PubMed ID: 38267981
[TBL] [Abstract][Full Text] [Related]
12. Analysis of HPV prevalence among individuals with reproductive tract infections in a Chinese population.
Zhou YX; Wang L; Wang TT; Qu XL; Zhang XQ
Medicine (Baltimore); 2023 Oct; 102(41):e34989. PubMed ID: 37832113
[TBL] [Abstract][Full Text] [Related]
13. Independent risk factors for high-risk human papillomavirus infection among rural women in Shanxi Province, China: a population-based, case-control study.
Shi R; Qi W; Cai J; Zhao M; Wang Z
Arch Gynecol Obstet; 2023 Aug; 308(2):551-559. PubMed ID: 36814027
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and genotype distribution of HPV6/11/16/18 infections among 180,276 outpatient females from a Women's and Children's Central Hospital, 2015-2021, Chengdu, China.
Wei X; Zhang J; Mei Y; Dai Q; Yang X; Wang X
Sci Rep; 2023 Dec; 13(1):22249. PubMed ID: 38097632
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Genotype Patterns Associated With High-Risk Human Papillomavirus in Cervical Lesions.
Kothari V; Khullar S; Ts H
Cureus; 2024 Apr; 16(4):e58300. PubMed ID: 38752031
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China.
Thomsen LT; Kjær SK
BMC Med; 2021 Jul; 19(1):165. PubMed ID: 34261466
[No Abstract] [Full Text] [Related]
17. The Prevalence of Cervical HPV Infection and Genotype Distribution in 856,535 Chinese Women with Normal and Abnormal Cervical Lesions: A Systemic Review.
Yu YQ; Hao JQ; Mendez MJG; Mohamed SB; Fu SL; Zhao FH; Qiao YL
J Cytol; 2022; 39(4):137-147. PubMed ID: 36605868
[TBL] [Abstract][Full Text] [Related]
18. Estimated prevalence of human papillomavirus among Nigerian women: A systematic review and meta-analysis.
Anoruo O; Bristow C; Mody N; Klausner JD
Afr J Reprod Health; 2022 Jun; 26(6):89-96. PubMed ID: 37585061
[TBL] [Abstract][Full Text] [Related]
19. Distribution patterns of human papillomavirus genotypes among women in Guangzhou, China.
Li S; Zhang K; Yang L; Wu J; Bhargava N; Li Y; Gao F
Infect Agent Cancer; 2023 Oct; 18(1):67. PubMed ID: 37907979
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of HPV among 164,137 women in China exhibited some unique epidemiological characteristics.
Chen Q; Qu W; Zhao Y; Shu L; Wang Y; Chen X
Infect Agent Cancer; 2023 Nov; 18(1):72. PubMed ID: 37950328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
